Interestingly, NTSR1 internalization, which is overactive in cancer cells [11], has become an efficient pathway to introduce therapeutic genes that are intravenously delivered by the NTS-polyplex nanoparticles as we previously demonstrated in a murine neuroblastoma model [24]. The gene discussed is NTSR1; the disease is neuroblastoma.